Alejandra Trejo - Concepedia

Author

Alejandra Trejo

Also Known As

A Cárabez Trejo, A. TREJO, A. Trejo, A.I. Mendieta Trejo, ALEJANDRA TREJO, Alejandra Trejo

Publications

266

Citations

H-Index

Concepts

All Affiliations

Alejandra Trejo is an author at Roche (United States) specializing in drug discovery, medicinal chemistry, and natural sciences.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	168
2	Natural Sciences	2	2	168
3	Biochemistry	2	2	168
4	Pharmacology	2	2	168
5	Rheumatology	1	1	74

Alejandra Trejo

Publications

232

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase Alejandra Trejo, Humberto Arzeno, Michelle F. Browner, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryP38 Map KinaseP38 InhibitorsOrganic Chemistry	2003	94
Discovery of 6-(2,4-Difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8<i>H</i>-pyrido[2,3-<i>d</i>]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2<i>H</i>-pyran-4-ylamino)pyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-one (R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α Mitogen-Activated Protein Kinase David Goldstein, Michael Soth, Tobias Gabriel, Journal of Medicinal Chemistry PharmacotherapyNew SeriesSystem PharmacologyPharmaceutical ChemistryPre-clinical Pharmacology	2011	74
Discovery of <i>S</i>-[5-Amino-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an Orally Bioavailable and Highly Selective Inhibitor of p38 Map Kinase David Goldstein, Tom Alfredson, J. A. Bertrand, Journal of Medicinal Chemistry	2006	64

Page 1